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Nontuberculous mycobacterial pulmonary infection (NTM) mainly occurs due to
the inhalation of organisms which are present in the environment. In immuno-
competent patients, the occurrence rate has been gradually increasing as the major
cause of chronic infection.
1 Of these, mycobacterium avium complex (MAC) is
one of the most common worldwide human pathogens causing NTM, and it
accounts for more than 70% of pathogens causing NTM lung disease.
2-4
MAC lung disease is divided into two subtypes, cavitary type and nodular
bronchiectatic type, each of which has been reported to feature different clinical
presentations and radiologic manifestations.
1 The cavitary type is observed to be a
heterogeneous nodular with cavitary opacities involving upper lobe on CT scans,
and it occurs in elderly male patients with a smoking history or those who had
underlying lung diseases, such as chronic obstructive pulmonary disease or
pulmonary fibrosis. In contrast, the nodular bronchiectatic type MAC (NB-MAC)
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Purpose: The objective of this study is to define the clinical implications of con-
solidations in nodular bronchiectatic type Mycobacterium avium complex (NB-
MAC) infection. Materials and Methods: A total of 69 patients (M : F = 17 : 52;
mean age, 64 years; age range, 41-85 years) with MAC isolated in the sputum
culture and nodular bronchiectasis on the initial and follow-up CT scans were
included. We retrospectively reviewed the incidence of consolidation and analyzed
its clinical course by using radiographic changes with or without anti-MAC drug
therapy. Results: In 44 of the 69 cases (64%), focal consolidations were seen on
the initial and follow-up CT images. In 35 of the 44 (80%) cases, consolidations
completely regressed, and in 3 cases (7%), consolidations partially regressed
within 2 months with only antibiotics. In 2 cases (5%), the consolidations remained
stable for over 2 months without anti-MAC drug therapy. Only in 4 cases (9%) did
the consolidations improve after anti-MAC drug therapy. In 11 of the 38 cases
(29%) with responsiveness to antibiotics, non-mycobacterial micro-organisms were
identified in sputum, including pseudomonas, hemophilus, staphylococcus, and
others. Conclusion: In NB-MAC, consolidations are commonly present on CT. In
these conditions, most of consolidations result from pneumonia other than MAC.
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INTRODUCTIONoccurs in elderly women who lack any underlying lung
disease. In these patients, the characteristic CT findings
include cylindrical bronchiectasis and centrilobular nodules
with tree in bud. These findings are particularly seen in the
middle lobe or lingula. In addition, there can also be such
findings as consolidation and cavitation.
5-7 Of these, bron-
chiectasis and cavitation in the related histopathologic find-
ings as well as CT findings have been well documented.
With regards to the consolidation, however, there were
reports about various incidences. But, its significance or
histopathological findings have rarely been described.
8-11
Given this background, we attempted to clarify the clinical
implications of consolidations of NB-MAC.
Between May 2003 and December 2007, 119 patients with
MAC (M : F = 42 : 77; mean age 64, years; age range, 41-
87 years) underwent a CT scan in our institute. An initial
chest CT scan was performed for without underlying lung
diseases or differentiating from MAC mimicking diseases
such as tuberculosis or diffuse panbronchiolitis. A follow-
up CT scan was obtained in patients with progressive symp-
toms or new lesions on a plain chest radiography. Sixty
nine patients of 119 (M : F = 17 : 52; mean age, 64 years;
age range, 41-85 years) showed nodules and bronchiectasis
in the lung on the CT scans. All patients were immuno-
competent. We checked the presence of consolidation on
the CT scans of 69 patients with NB-MAC and at this time,
consolidation was defined as a homogeneous increase in
pulmonary parenchymal attenuation that obscured the
margins of vessels and airway walls according to the Re-
commendations of the Nomenclature Committee of the
Fleischner Society.
12
Incidence of consolidation and its clinical course were
analyzed using radiographic changes with or without anti-
NTM chemotherapy. Exclusively in patients with consoli-
dation, their clinical courses were classified as the group
where there was NTM medication and where there was a
lack of it. Incidence of consolidation on the initial CT scan
and newly identified consolidation on the follow-up (FU)
CT was analyzed. In patients with consolidation, their
clinical courses with empirical antibiotic treatment only or
anti-NTM chemotherapy were analyzed using radiogra-
phic changes. In each group, follow-up images were taken
within a 2-month period. Based on these follow-up images,
each group was divided into the responder group where
there was a change and the non-responder group where
there was a lack of change. All these patients fulfilled the
1997 American Thoracic Society criteria for the diagnosis
of nontuberculous mycobacterial disease. The Institutional
Review Board of our institution approved this retrospec-
tive study. 
Two CT scanners (Volume Zoom, Siemens, Forchheim,
Germany; LightSpeed, GE Healthcare, Milwaukee, WI,
USA) were used. All scans were reconstructed into axial
images with 5-mm slice thickness at 5-mm intervals. Both
unenhanced and contrast-enhanced images were obtained.
Two radiologists retrospectively reviewed the CT images
with a consensus on a 2,048×2,560 Picture Archiving and
Communication Systems Monitor (PACS; Marotech,
Seoul, Korea). 
In 44 of 69 cases (64%), consolidations were seen on CT
images. Of these, 14 cases had a consolidation detected on
the initial CT (Figs. 1 and 2). In the remaining 30 cases, a
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Fig. 1. A 45-year-old woman with NB-MAC, initially presenting with consolidation. (A) Plain chest radiography shows an ill-defined ovoid
consolidation in left middle lung zone (arrow). (B) Initial CT scans shows mild cylindrical bronchiectasis and adjacent centrilobular nodules in right
middle lobe and lingula, suggestive of NB-MAC. A focal consolidation is seen in subpleural region of lingula (double arrows). (C) FU plain
radiography after 2 weeks shows disappearance of the prior focal consolidation after antibiotic therapy. NB-MAC, nodular bronchiectatic type
Mycobacterium avium complex; FU,  follow-up.
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Fig. 3. A 53-year-old women with NB-MAC, who had newly detected consolidations during FU period managed with empirical antibiotic therapy.
(A) Initial CT shows bronchiectasis with atelectasis and nearby clustered micronodules in right middle lobe. Faint nodular opacities are also visible
at posterior aspect of right lower lobe (arrowheads). (B) Six-month FU HRCT at the same level to A shows a new irregular consolidation at
posterior subpleural region of right lower lobe (arrow). Another smaller consolidation is seen in right middle lobe (double arrows). Bronchiectasis
and clustered centrilobular nodules of right middle lobe, indicative of NB-MAC, are more clearly demarcated than before. The pre-existing faint
nodules of right lower lobe are invisible, suggestive of improvement of focal bronchiolitis. (C) One-month FU HRCT after antibiotic therapy shows
complete regression of the prior consolidations in right middle and lower lobes. NB-MAC, nodular bronchiectatic type Mycobacterium avium
complex; FU,  follow-up; HRCT, high-resolution CT.
A B C
Fig. 4. A 72-year-old man with NB-MAC, who had newly detected consolidations during FU with response to anti-MAC therapy. (A) Axial CT
shows multifocal cylindrical bronchiectasis and centrilobular nodules with volume loss in both lungs. Irregular consolidations are seen at posterior
aspect of right lower lobe (arrow). Anti-MAC therapy was initiated. (B) Plain radiograph obtained at the same day to A shows multifocal
consolidations and small nodular opacities in right lung and left lower lung zone. (C) FU plain radiography after 2 months shows decreased extent
of the consolidations and nodules of both lungs. NB-MAC, nodular bronchiectatic type Mycobacterium aviumcomplex; FU,  follow-up.
AB C
Fig. 2. A 48-year-old man with NB-MAC, who had a consolidation without response to antibiotics. (A and B) Initial CT shows multifocal clusters of
centrilobular nodules with tree in bud appearance in right upper and middle lobes and lingula (arrowheads). Peripheral airways of right upper lobe
are minimally dilated (thin arrow). A focal consolidation is seen at anterior subpleural region of lingula (arrow). (C) Two-month FU CT shows little
change in size of the prior consolidation in lingula (double arrows) after empirical antibiotics. NB-MAC, nodular bronchiectatic type
Mycobacterium aviumcomplex; FU,  follow-up.
A BCconsolidation was newly identified on the FU CT while
only a nodular bronchiectasis was identified on the initial
CT (Figs. 3 and 4). The mean follow-up interval between
the period during which an initial CT diagnosis of NTM
and the time of a new consolidation on the CT was per-
formed and a follow-up CT based on which a consolida-
tion was newly identified was 19 months (2-47 months). 
Of the 44 patients, 40 underwent empirical treatment
with antibiotics. Macrolide therapy was not introduced in
most cases. In a total of 95% of patients with empirical
treatment (38/40), a regression of the consolidation was
achieved within two months. Of these patients of the anti-
biotics responder group, 35 patients (88%, 35/40) showed
that a consolidation completely regressed (Figs. 1 and 3).
In three patients (7%, 3/40), it partially regressed. Of these,
such non-NTM bacterial strains as pseudomonas, hemo-
philus and staphylococcus were isolated on the sputum
culture in 11 cases. In 2 cases (5%, 2/40), the consolida-
tions were not responsive to antibiotics; however, they re-
mained stable for over 2 months without anti-MAC chemo-
therapy (Fig. 2). 
Anti-NTM chemotherapy with macrolides was initiated
in four residual patients under consideration of disease pro-
gression, and consolidation completely regressed in two
patients and partially regressed in two patients in 2 months
(Fig. 4) (Table 1). Anti-NTM chemotherapy was maintained
using 12 months of culture negativity as the treatment end
point. 
The responsiveness to the antibiotics or anti-NTM chemo-
therapy is summarized in Table 1.
In cases of NB-MAC, centrilobular nodules and cylindrical
bronchiectasis are typical CT findings. A histopathological
background of these findings has been well documented.
The characteristic pathological finding of MAC lung disease
was extensive granuloma formation from the large airway
to the bronchiole. In the bronchiole, a peribronchial gra-
nuloma protruded into the lumen which resulted in the
narrowing of the bronchiole. In addition, ulceration of the
bronchial wall with ensuing disruption of the muscle layer
was frequently observed, which may have caused bron-
chiectatic changes. Centrilobular nodules might have been
caused by transbronchial dissemination of necrotic mater-
ials found in the lumen of the bronchiole.
8-11
NB-MAC shows a tendency that symptoms are of mild
severity and it has a slow progression. It therefore requires
the time extending from approximately 5 years to 10 years.
Accordingly, the treatment decision on MAC lung disease
is commonly made following a careful interpretation of the
patients’ overall status and each respiratory MAC isolate.
In an actual clinical setting, prior to the suspicion of disease
progression, a monitoring of the clinical courses is routinely
done without specific treatments. Accordingly, in patients
with NB-MAC, the changes in the radiologic findings can
be objective evidence suggestive of disease progression. It
can therefore be an important indicator for determining
anti-MAC therapy. Actually, according to Wickreman-
singhe, et al., bronchiectasis was aggravated on CT find-
ings in some patients with NB-MAC for whom the treat-
ment was performed. Besides, there were also findings of
cavities and consolidation.
1,13
In patients with NB-MAC, although rare, there can be a
concurrent presence of cavitation or consolidation. In cases
in which there is a cavitary lesion, the inflammation pro-
gressed to the adjacent region to bronchiectasis. Otherwise,
it has been known as a mixed form of a cavitary type and
nodular bronchiectatic type. According to Kim, et al.,
9 the
cavitary lesion of MAC lung disease occurred due to the
formation of large cystic bronchiectasis after inflammation
developed in a nodular bronchiectatic form. According to
Okumura, et al.,
14 however, nodular bronchiectatic type
can be aggravated but it will not progress to the cavitary
lesion. However, it triggers the occurrence of repeated
bronchogenic spread around the main focus. 
On the other hand, the frequency or histopathologic
findings of consolidation have rarely been reported. This
might be because a surgical approach cannot be easily
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Table 1.Responsiveness of Consolidations to Antibiotics and Anti-NTM Chemotherapy within Two Months
Consolidation Management Responsiveness
Initial CT (n = 14) Antibiotics (n = 14) Complete (n = 10)
Partial (n = 2)
No (n = 2)
FU CT (n = 30) Antibiotics (n = 26) Complete (n = 25)
Partial (n = 1)
Anti-NTM (n = 4) Complete (n = 2)
Partial (n = 2)
NTM, nontuberculous mycobacterial pulmonary infection; FU, follow-up.
DISCUSSIONcompleted considering the clinical characteristics of NB-
MAC. There are reports about incidences of consolidation,
most of which have described as the cavitary type together
with the nodular bronchiectatic type.
8,9,15 Jeong, et al.
8 per-
formed a correlation analysis using a lobectomy specimen.
These authors reported that a consolidation was centrally
located caseating granulomas and marginal non-specific
inflammation. Fujita, et al.
11 reported that it had loosely
grouped granulomas and/or coalescent inflammatory infilt-
rates completely replaced normal alveoli, edema, and con-
gestion in alveolar lesions adjacent to the granulomas.
However, these authors did not differentiate between these
two subtypes of MAC lung disease.
Before starting the present study, we have concentrated
on the consolidation whose concurrent presence was newly
found to be at a follow-up in patients with NB-MAC. Then,
we have also speculated that NB-MAC disease progres-
sion might be indicated based on the consolidation which
was newly developed or concurrently present at the time of
the initial diagnosis during a monitoring of the clinical
courses in patients with NB-MAC. It is difficult to histo-
pathologically demonstrate all the consolidations that have
been observed in patients with MAC. In most of the pati-
ents, however, prior to the initiation of MAC chemotherapy,
based on whether conservative or antibiotic therapy would
be performed, the presence of responses was assessed. 
In our series, the proportion of cases in which a consoli-
dation was observed at the time of the initial diagnosis or
during a monitoring of the clinical courses amounted to
64%. These results indicate that the frequency is relatively
higher. Of these, 87% had improved symptoms only after
empirical antibiotic treatment within 2 months. These res-
ponses indicate that a consolidation is pneumonia originat-
ing from other causes rather than granulomatous inflam-
mation in patients with NB-MAC. Besides, this implies
that a newly developed consolidation is not an image find-
ing which is suggestive of disease progression.
The limitations of the current study include selection
bias. Firstly, usual clinical presentations of NB-MAC are
mild chronic cough or productive sputum, although the
symptoms are variable and nonspecific. Based on the
clinical characteristics of NB-MAC, most of the cases are
asymptomatic. However, in patients who visited our medi-
cal institution, there were many cases in which new symp-
toms or progressive symptoms developed. Accordingly,
many patients with superimposed pneumonia were includ-
ed in our study. Secondly, the conclusions were drawn
from the presence of treatment response to the isolated
bacterial strains and antibiotics rather than a direct com-
parison with the histopathological findings. Considering
the clinical courses of NB-MAC, a surgical approach
could not be made. Actually, in most of the patients, con-
solidation improved. Thus, a histopathological demon-
stration could not be made.
Consequently in cases of NB-MAC, bronchial and peri-
bronchial inflammation mainly occurs and this leads to the
subsequent occurrence of bronchiectasis with centrilobular
nodules. But there are rare cases in which a consolidation
occurs due to lung parenchymal invasion of MAC in NB-
MAC. Besides, a consolidation which occurs during a
follow-up study cannot be considered disease progression.
Before attempting anti-MAC chemotherapy, the conserva-
tive or empirical antibiotic treatments would be of great
help.
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